Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Axis-Shield and Abbott sign development and manufacturing agreement
According to Axis-Shield, Active-B12 is a more efficient method for detection of vitamin B12 deficiency compared to the measurement of total B12 in the blood, as it measures
According to Axis-Shield, Active-B12 is a more efficient method for detection of vitamin B12 deficiency compared to the measurement of total B12 in the blood, as it measures
Crucell will receive an upfront payment of $1.5 million following the execution of the agreement and will be eligible for milestone payments of approximately $20 million. Further financial
Under the terms of the alliance, Dynavax will receive an initial payment of $10 million for which GlaxoSmithKline (GSK) will receive an exclusive option over four programs targeting
In this role, Mr Pacelli will oversee DexCom’s key administrative functions, including finance, corporate development, managed care, legal, human resources, intellectual property and investor relations. Mr Pacelli has
As a consequence, Centinel Spine now has exclusive distribution rights to market Stalif TT products in all markets and countries globally. Centinel Spine expects to see increased revenue
The ProScan test is based on key peer-reviewed studies that identified several genetic tumor markers that enable a more precise stratification of the risk profile of cancer patients.
The licenses will provide Enigma full access under patents owned or licensed by Roche Molecular Systems and its affiliates to practice HybProbe real-time polymerase chain reaction (PCR) chemistry.
As part of this transaction, Theratechnologies has received an upfront payment of $30 million which includes a license fee of $22 million from EMD Serono and an equity
According to the company, the target market for the instrument includes university hospitals, high throughput general hospitals, high volume commercial laboratories and reference laboratories. Ronan Caoimh, CEO of
Ingen expects to realize about 1-2% of those markets within 24 months, which would result in a $10 million revenue stream during 2009 and 2010. The company, recognizing